河北医科大学学报 ›› 2025, Vol. 46 ›› Issue (5): 548-553.doi: 10.3969/j.issn.1007-3205.2025.05.009

• • 上一篇    下一篇

全腹平扫CT在胃肠间质瘤靶向治疗疗效评估中的应用价值

  

  1. 1.河北医科大学第四医院CT磁共振科,河北 石家庄 050011;2.河北医科大学第四医院科研中心,河北 石家庄 050011

  • 出版日期:2025-05-25 发布日期:2025-05-23
  • 作者简介:郝清(1997-),女,河北霸州人,河北医科大学第四医院医师,医学硕士,从事胃肠道肿瘤影像研究。

  • 基金资助:
    河北省省级科技计划资助项目(22377789D)

The application value of whole abdominal plain CT in the assessment of the efficacy of targeted therapy for gastrointestinal stromal tumours

  1. 1.Department of CT/MRI, the Fourth Hospital of Hebei Medical University, Shijiazhuang 
    050011, China; 2.Department of Scientific Research centre, the Fourth Hospital of 
    Hebei Medical University, Shijiazhuang 050011, China

  • Online:2025-05-25 Published:2025-05-23

摘要: 目的 评价全腹平扫CT在胃肠间质瘤(gastrointestinal stromal tumors,GIST)靶向治疗疗效评估中的应用价值。
方法 回顾性分析2015年3月—2022年9月河北医科大学第四医院收治的经病理证实、接受靶向治疗且治疗前后影像资料完整的GIST患者53例。参照实体瘤疗效评价标准实体肿瘤反应评估(Response Evaluation Criteria in Solid Tumors,RECIST)1.1选取靶病灶,分别于平扫和静脉期图像测量治疗前后靶病灶的长径及CT衰减值,计算长径之和变化率及平均CT值变化率,观察有无新发病灶、靶病灶有无新发出血及钙化,参照RECIST 1.1及Choi两种标准评估疗效。对比平扫及静脉期疗效评估结果。记录各次检查平扫及增强CT扫描的辐射剂量。
结果 平扫与静脉期测量的靶病灶长径之和、长径之和变化率的差异均无统计学意义(P均>0.05),且一致性很强[组内相关系数(intraclass correlation coefficient,ICC)值分别为1.000、0.999];两者测量的靶病灶平均CT值变化率的差异有统计学意义(P<0.05),但一致性较强(ICC值为0.672);治疗后出现3例新发病灶,3例瘤内出血,5例瘤内钙化,均可被平扫识别。参照RECIST1.1标准、Choi标准,平扫与静脉期疗效评估结果一致性均很强,Kappa值分别为1.000(P<0.05)、 0.882(P<0.05)。平扫较增强扫描辐射剂量降低约70.11%。
结论 全腹平扫CT降低了患者的辐射暴露及检查费用,可以较为准确地评估胃肠间质瘤靶向治疗效果,具有一定的临床应用价值。


关键词: 胃肠道间质肿瘤, 多探头的计算机断层扫描, 靶向治疗

Abstract: Objective To evaluate the application value of whole abdominal plain CT in the assessment of the efficacy of targeted therapy for gastrointestinal stromal tumors (GIST). 
Methods Fifty-three patients with pathologically confirmed GIST who received targeted therapy and had complete pre-and post-treatment imaging were retrospectively analyzed in the Fourth Hospital of Hebei Medical University from Mar. 2015 to Sept. 2022. The target lesions were selected with reference to the solid tumor efficacy evaluation criteria Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. The length diameters and CT attenuation values of the target lesions before and after treatment were measured on the plain and venous images, respectively, and the rate of change in the sum of the length diameter and that in the mean CT value were calculated. Observations were made to determine the presence of new lesions, new hemorrhages in target lesions, and calcifications. Efficacies were evaluated according to both the RECIST1.1 and Choi criteria. The results of the efficacy assessment of the scanning and venous phases were compared. Radiation doses were recorded of each examination for both plain and enhanced CT scans. 
Results The differences between the sum of the length diameters of the target lesions and the change rate of the sum of the length diameters measured in the plain and venous phases were not statistically significant (both P>0.05) and were in good agreement [intraclass correlation coefficient (ICC) values of 1.000 and 0.999, respectively]. The difference in the change rate of the mean CT values of the target lesions measured by both was statistically significant (P<0.05), but the consistency was strong (ICC value of 0.672). Three new lesions, three intratumoral hemorrhages, and five intratumoral calcifications appeared after treatment, all of which could be identified by plain scanning. With reference to the RECIST1.1 criteria and Choi criteria, the consistency in the assessment results of the efficacy of the plain and venous phases was very strong, with Kappa values of 1.000 (P<0.05) and 0.882 (P<0.05), respectively. Radiation dose reduced approximately 70.11% for plain scan compared with enhanced scan. 
Conclusion The whole abdominal plain CT scan reduces the radiation exposure and examination expenses of patients and can evaluate the targeted therapeutic effect of gastrointestinal stromal tumors relatively accurately, which has certain clinical application value. 


Key words: gastrointestinal stromal tumors, multi-detector computed tomography, targeted therapy